Bone Marrow Transplantation - Table of Contents alert Volume 50 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 50, Issue 6 (June 2015) In this issue Editorial Reviews Special Report Original Articles Letters to the Editor Erratum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement International Journal of Oral Science Review - Fibroblast growth factor 23 (FGF23) is a hormone that is mainly secreted by osteocytes and osteoblasts in bone. Studies have revealed that the levels of FGF23 increase significantly at the very early stages of chronic kidney disease (CKD) and may play a critical role in mineral ion disorders and bone metabolism in these patients. Download PDF   Editorial Top The importance of long-term follow-up in pediatric hematopoietic stem cell transplantation D A Jacobsohn Bone Marrow Transplant 2015 50: 749-750; advance online publication, April 13, 2015; 10.1038/bmt.2015.70 Full Text Reviews Top Donor HLA-specific Abs: to BMT or not to BMT? M S Leffell, R J Jones and D E Gladstone Bone Marrow Transplant 2015 50: 751-758; advance online publication, February 23, 2015; 10.1038/bmt.2014.331 Abstract | Full Text Reduced-intensity conditioned allogeneic SCT in adults with AML R Reshef and D L Porter Bone Marrow Transplant 2015 50: 759-769; advance online publication, March 2, 2015; 10.1038/bmt.2015.7 Abstract | Full Text Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma N Lendvai, A D Cohen and H J Cho Bone Marrow Transplant 2015 50: 770-780; advance online publication, March 9, 2015; 10.1038/bmt.2015.5 Abstract | Full Text Special Report Top Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT) OPEN M Mohty, F Malard, M Abecassis, E Aerts, A S Alaskar, M Aljurf, M Arat, P Bader, F Baron, A Bazarbachi, D Blaise, F Ciceri, S Corbacioglu, J-H Dalle, R F Duarte, T Fukuda, A Huynh, T Masszi, M Michallet, A Nagler, M NiChonghaile, T Pagluica, C Peters, F B Petersen, P G Richardson, T Ruutu, B N Savani, E Wallhult, I Yakoub-Agha and E Carreras Bone Marrow Transplant 2015 50: 781-789; advance online publication, March 23, 2015; 10.1038/bmt.2015.52 Abstract | Full Text Original Articles Top LYMPHOMA Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party K Horstmann, A Boumendil, J Finke, H Finel, E Kanfer, G Milone, N Russell, A Bacigalupo, Y Chalandon, J L Diez-Martin, N Ifrah, M Jurado Chacon and P Dreger Bone Marrow Transplant 2015 50: 790-794; advance online publication, March 9, 2015; 10.1038/bmt.2015.12 Abstract | Full Text Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC M Strullu, C Thomas, M-C Le Deley, A Chevance, J Kanold, Y Bertrand, C Jubert, J-H Dalle, C Paillard, A Baruchel, L Lamant, G Michel and L Brugières Bone Marrow Transplant 2015 50: 795-801; advance online publication, March 30, 2015; 10.1038/bmt.2015.57 Abstract | Full Text PLASMA CELL DISORDERS Comparison of upfront tandem autologous–allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma F Sahebi, S Iacobelli, A V Biezen, L Volin, P Dreger, M Michallet, P T Ljungman, T de Witte, A Henseler, N P M Schaap, L López-Corral, X Poire, J Passweg, R-M Hamljadi, S H Thomas, S Schonland, G Gahrton, C Morris, N KrÖger and L Garderet on behalf of the Plasma Cell Disorders Subcommittee of the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancies Working Party Bone Marrow Transplant 2015 50: 802-807; advance online publication, March 23, 2015; 10.1038/bmt.2015.45 Abstract | Full Text Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT M Grövdal, H Nahi, G Gahrton, J Liwing, A Waage, N Abildgaard, P T Pedersen, J Hammerstrøm, A Laaksonen, P Bazia, V Terava, H Ollikainen, R Silvennoinen, M Putkonen, P Anttila, K Porkka and K Remes Bone Marrow Transplant 2015 50: 808-812; advance online publication, April 13, 2015; 10.1038/bmt.2015.39 Abstract | Full Text HEMATOPOIETIC CELL COLLECTION G-CSF plus preemptive plerixafor vs hyperfractionated CY plus G-CSF for autologous stem cell mobilization in multiple myeloma: effectiveness, safety and cost analysis A Antar, Z K Otrock, M A Kharfan-Dabaja, H A Ghaddara, N Kreidieh, R Mahfouz and A Bazarbachi Bone Marrow Transplant 2015 50: 813-817; advance online publication, March 9, 2015; 10.1038/bmt.2015.23 Abstract | Full Text GRAFT SOURCE Impact of length of cryopreservation and origin of cord blood units on hematologic recovery following cord blood transplantation N Kurita, F Frassoni, S Chiba and M Podestà Bone Marrow Transplant 2015 50: 818-821; advance online publication, March 23, 2015; 10.1038/bmt.2015.56 Abstract | Full Text CELLULAR THERAPY The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs L E Franssen, N W C J van de Donk, M E Emmelot, M W H Roeven, N Schaap, H Dolstra, W Hobo, H M Lokhorst and T Mutis Bone Marrow Transplant 2015 50: 822-828; advance online publication, March 23, 2015; 10.1038/bmt.2015.48 Abstract | Full Text CONDITIONING Preferential depletion of host over donor T cells through in vivo decay of active rabbit-anti-thymocyte globulin levels during reduced intensity conditioning M Sanacore, X Zhang, S L Brown, K Connor, S Hilton, L E Morris, H K Holland, S R Solomon and A Bashey Bone Marrow Transplant 2015 50: 829-833; advance online publication, March 23, 2015; 10.1038/bmt.2015.41 Abstract | Full Text HISTOCOMPATIBILITY AND DONOR SELECTION ISSUES Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites B K Hamilton, L Rybicki, M Sekeres, M Kalaycio, R Hanna, R Sobecks, R Dean, H Duong, B T Hill, B Bolwell and E Copelan Bone Marrow Transplant 2015 50: 834-839; advance online publication, March 23, 2015; 10.1038/bmt.2015.44 Abstract | Full Text SUPPORTIVE CARE Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients E Lengliné, S Chevret, A-S Moreau, F Pène, F Blot, J-H Bourhis, A Buzyn, B Schlemmer, G Socié and E Azoulay Bone Marrow Transplant 2015 50: 840-845; advance online publication, March 23, 2015; 10.1038/bmt.2015.55 Abstract | Full Text Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience O Nikolajeva, A Mijovic, D Hess, E Tatam, P Amrolia, R Chiesa, K Rao, J Silva and P Veys Bone Marrow Transplant 2015 50: 846-849; advance online publication, March 30, 2015; 10.1038/bmt.2015.53 Abstract | Full Text TRANSPLANT TOXICITIES Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT—two decades of longitudinal follow-up M Wilhelmsson, A Vatanen, B Borgström, B Gustafsson, M Taskinen, U M Saarinen-Pihkala, J Winiarski and K Jahnukainen Bone Marrow Transplant 2015 50: 850-857; advance online publication, March 23, 2015; 10.1038/bmt.2015.43 Abstract | Full Text INFECTIONS Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study A Ambati, L S V Boas, P Ljungman, L Testa, J F de Oliveira, M Aoun, V Colturato, M Maeurer and C M Machado Bone Marrow Transplant 2015 50: 858-864; advance online publication, March 23, 2015; 10.1038/bmt.2015.47 Abstract | Full Text Letters to the Editor Top Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available S Garciaz, L Castagna, R Bouabdallah, S Fürst, S Bramanti, D Coso, R Crocchiolo, J El-Cheikh, F Broussais, C Chabannon, A Santoro and D Blaise Bone Marrow Transplant 2015 50: 865-867; advance online publication, March 2, 2015; 10.1038/bmt.2015.22 Full Text Serum free light chain trends between orthotopic heart transplantation and auto-SCT in patients with AL amyloidosis A S Renteria, V Sanchorawala, E D Niehaus, F Sun, M J Semigran and D C Seldin Bone Marrow Transplant 2015 50: 868-869; advance online publication, March 9, 2015; 10.1038/bmt.2015.9 Full Text Very late-onset reversible cardiomyopathy in patients with chronic GvHD H Kawano, H Tanaka, T Yamashita, K-i Hirata, S Ishii, T Suzuki, K Wakahashi, Y Kawano, A Sada, K Minagawa, F Kawakami, T Itoh, A Baba, T Matsui and Y Katayama Bone Marrow Transplant 2015 50: 870-872; advance online publication, March 23, 2015; 10.1038/bmt.2015.40 Full Text Pre-transplant sirolimus might improve the outcome of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide for patients with severe aplastic anemia S R Jaiswal, S Chatterjee, S Mukherjee, K Ray and S Chakrabarti Bone Marrow Transplant 2015 50: 873-875; advance online publication, March 23, 2015; 10.1038/bmt.2015.50 Full Text Prognostic significance of liver parameters at 1-year follow-up in children and adults undergoing myeloablative allogeneic stem cell transplantation K Jordan, I J Christensen, M H Jørgensen, C Heilmann, H Sengeløv and K G Müller Bone Marrow Transplant 2015 50: 876-877; advance online publication, March 23, 2015; 10.1038/bmt.2015.54 Full Text Immortal person-time bias in the association between herpes zoster and survival following autologous stem cell transplantation S A J Schmidt and T L Lash Bone Marrow Transplant 2015 50: 878-879; advance online publication, March 30, 2015; 10.1038/bmt.2015.66 Full Text Erratum Top Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available S Garciaz, L Castagna, R Bouabdallah, S Fürst, S Bramanti, D Coso, R Crocchiolo, J El-Cheikh, F Broussais, C Chabannon, A Santoro and D Blaise Bone Marrow Transplant 2015 50: 880; 10.1038/bmt.2015.79 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.